EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ATF3 is a neuron‐specific biomarker for spinal cord injury and ischaemic stroke

Jonathan Z Pan, Zhanqiang Wang, Wei Sun, Peipei Pan, Wei Li, Yongtao Sun, Shoulin Chen, Amity Lin, Wulin Tan, Liangliang He, Jacob Greene iD, Virginia Yao und 36 weitere

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Jonathan Z Pan und 47 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Activating Transcription Factor 3, Biomarkers, Ischemic Stroke, Neurons. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although many molecules have been investigated as biomarkers for spinal cord injury (SCI) or ischemic stroke, none of them are specifically induced in central nervous system (CNS) neurons following injuries with low baseline expression. However, neuronal injury constitutes a major pathology associated with SCI or stroke and strongly correlates with neurological outcomes. Biomarkers characterized by low baseline expression and specific induction in neurons post‐injury are likely to better correlate with injury severity and recovery, demonstrating higher sensitivity and specificity for CNS injuries compared to non‐neuronal markers or pan‐neuronal markers with constitutive expressions.

Methods

In animal studies, young adult wildtype and global Atf3 knockout mice underwent unilateral cervical 5 (C5) SCI or permanent distal middle cerebral artery occlusion (pMCAO). Gene expression was assessed using RNA‐sequencing and qRT‐PCR, while protein expression was detected through immunostaining. Serum ATF3 levels in animal models and clinical human samples were measured using commercially available enzyme‐linked immune‐sorbent assay (ELISA) kits.

Results

Activating transcription factor 3 (ATF3), a molecular marker for injured dorsal root ganglion sensory neurons in the peripheral nervous system, was not expressed in spinal cord or cortex of naïve mice but was induced specifically in neurons of the spinal cord or cortex within 1 day after SCI or ischemic stroke, respectively. Additionally, ATF3 protein levels in mouse blood significantly increased 1 day after SCI or ischemic stroke. Importantly, ATF3 protein levels in human serum were elevated in clinical patients within 24 hours after SCI or ischemic stroke. Moreover, Atf3 knockout mice, compared to the wildtype mice, exhibited worse neurological outcomes and larger damage regions after SCI or ischemic stroke, indicating that ATF3 has a neuroprotective function.

Conclusions

ATF3 is an easily measurable, neuron‐specific biomarker for clinical SCI and ischemic stroke, with neuroprotective properties. Highlights ATF3 was induced specifically in neurons of the spinal cord or cortex within 1 day after SCI or ischemic stroke, respectively. Serum ATF3 protein levels are elevated in clinical patients within 24 hours after SCI or ischemic stroke. ATF3 exhibits neuroprotective properties, as evidenced by the worse neurological outcomes and larger damage regions observed in Atf3 knockout mice compared to wildtype mice following SCI or ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activating Transcription Factor 3BiomarkersIschemic StrokeNeuronsSpinal Cord InjuriesAnimalsFemaleHumansMaleMiceDisease Models, AnimalMice, Knockout

Stichwörter der Autor:innen

activating transcription factor 3 (ATF3)biomarkerneuronal injuryneuroprotectionspinal cord injurystroke

Substanzen

Activating Transcription Factor 3ATF3 protein, humanAtf3 protein, mouseBiomarkers

Autor:innen und Institutionen

  • Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California, USA.
  • Center for Cerebrovascular Research, University of California San Francisco, San Francisco, California, USA.
  • Department of Neurology, Cangzhou People's Hospital, Cangzhou, China.
  • Department of Anesthesiology, Shandong Provincial Hospital, Shandong University, Jinan, China.
  • Department of Anesthesiology, Qianfoshan Hospital, Shandong University, Jinan, China.
  • Department of Anesthesiology, The Second Affiliated Hospital, Nanchang University, Nanchang, China.

ORCID-Profile: Jacob Greene, Zhonghui Guan

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • U.S. Department of Defense

Zitieren

APA

Pan, J. Z., Wang, Z., Sun, W., Pan, P., Li, W., Sun, Y., Chen, S., Lin, A., Tan, W., He, L., Greene, J., Yao, V., An, L., Liang, R., Li, Q., Yu, J., Zhang, L., Kyritsis, N., Fernandez, X. D., …, & Guan, Z. (2024). ATF3 is a neuron‐specific biomarker for spinal cord injury and ischaemic stroke. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1650

Vancouver

Pan JZ, Wang Z, Sun W, Pan P, Li W, Sun Y, et al. ATF3 is a neuron‐specific biomarker for spinal cord injury and ischaemic stroke. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1650

BibTeX
@article{Pan2024,
  author = {Pan, Jonathan Z and Wang, Zhanqiang and Sun, Wei and Pan, Peipei and Li, Wei and Sun, Yongtao and Chen, Shoulin and Lin, Amity and Tan, Wulin and He, Liangliang and Greene, Jacob and Yao, Virginia and An, Lijun and Liang, Rich and Li, Qifeng and Yu, Jessica and Zhang, Lingyi and Kyritsis, Nikolaos and Fernandez, Xuan Duong and Moncivais, Sara and Mendoza, Esmeralda and Fung, Pamela and Wang, Gongming and Niu, Xinhuan and Du, Qihang and Xiao, Zhaoyang and Chang, Yuwen and Lv, Peiyuan and Huie, J Russell and Torres-Espin, Abel and Ferguson, Adam R and Hemmerle, Debra D and Talbott, Jason F and Weinstein, Philip R and Pascual, Lisa U and Singh, Vineeta and DiGiorgio, Anthony M and Saigal, Rajiv and Whetstone, William D and Manley, Geoffrey T and Dhall, Sanjay S and Bresnahan, Jacqueline C and Maze, Mervyn and Jiang, Xiangning and Singhal, Neel S and Beattie, Michael S and Su, Hua and Guan, Zhonghui},
  title = {ATF3 is a neuron‐specific biomarker for spinal cord injury and ischaemic stroke},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1650}
}
Kostenlos starten →